Pulse nav.journalClub Tendencias Explorar Preguntas Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery | Synapse

March 1, 2012Open Access

Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The dose to be used should be 5 mg.

Me gusta

Guardar

Compartir

Ver artículo completo

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Esteve et al. (Thu,) studied this question.

synapsesocial.com/papers/69d7698fef4aa71f97f312a2 https://doi.org/https://doi.org/10.2147/ijwh.s28103

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mifepristone for the Treatment of Uterine Leiomyomas2008 · 93 citations
2Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU 4861993 · 68 citations
3[A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].1998 · 29 citations
4Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues.1980 · 178 citations
5Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study2010 · 123 citations